Sort
64,565 grants matching “drug discovery”
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation
$587,801Minoli A Perera · Northwestern University At Chicago · U54 · FY2017 · MD
Orally Active Nucleoside Phosphonates for Hepatitis C Virus
$587,665Robert Turner Schooley · University Of California, San Diego · R01 · FY2011 · AI
Mechanisms and rescue of craniosynostosis associated with gene-environment interaction
$587,652Jianfu Chen · University Of Southern California · R01 · FY2025 · DE
Targeting Aldehyde Dehydrogenase for Cancer Prevention
$587,645Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · CA
Harnessing the Unique Biogenesis of the Apicomplexan plastid organelle forAntimalarial Targets
$587,623Ellen Yeh · Stanford University · R01 · FY2020 · AI
Enhancing the C. elegans animal resource through genome editing
$587,575Ann E. Rougvie · University Of Minnesota · R24 · FY2019 · OD
Proj 3 - Targeting the Pro-tumorigenic Microenvironment
$587,566Yves A Declerck · Children'S Hosp Of Philadelphia · P01 · FY2020 · CA
Vanderbilt Network Lead Academic Participating Site for the NCTN
$587,562Jordan D Berlin · Vanderbilt University · U10 · FY2014 · CA
The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression
$587,559Nancy H. Colburn · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention
$587,559Nancy H. Colburn · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Nuclease Probe Mediated Sequencing
$587,489Debrah Thompson · Htg Molecular Diagnostics, Inc. · R44 · FY2014 · HG
Immunoaffinity Isolation of Phosphopeptides
$587,471Cell Signaling Technology, Inc. · R44 · FY2005 · CA
Antibiotic dereplication by transcriptome analysis
$587,303Karen E. Nelson · Northeastern University · P01 · FY2018 · AI
HIV neutralization and mechanisms of cellular entry
$587,287Sriram Subramaniam · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
CWRU/UHICC Phase I Trials of Anticancer Agents
$587,286Case Western Reserve University · U01 · FY2003 · CA
Transition State Analysis of Enzymatic Reactions
$587,271Vern L. Schramm · Albert Einstein College Of Medicine · R01 · FY2020 · GM
Development of Anticancer Agents
$587,204William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Genetics and Molecular Mechanisms of Prostate Cancer
$587,204William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
$587,093John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Development of class-IIa HDAC targeting PET probes for molecular imaging of disorders of the CNS
$587,037Nashaat Turkman · State University New York Stony Brook · R01 · FY2023 · AG
Clinical and Translational Science Award
$587,026Robert Stanley Sherwin · Yale University · TL1 · FY2007 · RR
Clinical and Translational Science Award
$587,026Robert Stanley Sherwin · Yale University · TL1 · FY2008 · RR
New Glycinergic Modulators as Potent Painkillers without Negative Psychoactive Effects
$587,020Yan Xu · University Of Pittsburgh At Pittsburgh · UG3 · FY2019 · NS
Genomic Studies in Charcot-Marie-Tooth Disease
$587,018Stephan Zuchner · University Of Miami School Of Medicine · R01 · FY2013 · NS
Clinical Core
$587,007Linda J Van Eldik · University Of Kentucky · P30 · FY2015 · AG